Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC3126394012;94013;94014 chr2:178547839;178547838;178547837chr2:179412566;179412565;179412564
N2AB2962289089;89090;89091 chr2:178547839;178547838;178547837chr2:179412566;179412565;179412564
N2A2869586308;86309;86310 chr2:178547839;178547838;178547837chr2:179412566;179412565;179412564
N2B2219866817;66818;66819 chr2:178547839;178547838;178547837chr2:179412566;179412565;179412564
Novex-12232367192;67193;67194 chr2:178547839;178547838;178547837chr2:179412566;179412565;179412564
Novex-22239067393;67394;67395 chr2:178547839;178547838;178547837chr2:179412566;179412565;179412564
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: S
  • RefSeq wild type transcript codon: AGC
  • RefSeq wild type template codon: TCG
  • Domain: Ig-151
  • Domain position: 46
  • Structural Position: 122
  • Q(SASA): 0.3763
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
S/C rs1482369519 -0.323 0.002 D 0.267 0.128 0.338834610459 gnomAD-2.1.1 4.02E-06 None None None None N None 0 0 None 0 5.58E-05 None 0 None 0 0 0
S/C rs1482369519 -0.323 0.002 D 0.267 0.128 0.338834610459 gnomAD-4.0.0 4.77328E-06 None None None None N None 0 0 None 0 2.77408E-05 None 0 0 5.71562E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
S/A 0.075 likely_benign 0.0751 benign -0.782 Destabilizing 0.025 N 0.266 neutral None None None None N
S/C 0.0916 likely_benign 0.0842 benign -0.719 Destabilizing 0.002 N 0.267 neutral D 0.535907848 None None N
S/D 0.3299 likely_benign 0.3041 benign -0.682 Destabilizing 0.124 N 0.268 neutral None None None None N
S/E 0.4112 ambiguous 0.3725 ambiguous -0.7 Destabilizing 0.055 N 0.267 neutral None None None None N
S/F 0.1487 likely_benign 0.1457 benign -1.219 Destabilizing 0.497 N 0.489 neutral None None None None N
S/G 0.0971 likely_benign 0.0942 benign -0.971 Destabilizing 0.042 N 0.245 neutral D 0.527576367 None None N
S/H 0.1975 likely_benign 0.1801 benign -1.554 Destabilizing 0.002 N 0.268 neutral None None None None N
S/I 0.1186 likely_benign 0.1133 benign -0.384 Destabilizing 0.096 N 0.403 neutral N 0.512492271 None None N
S/K 0.4056 ambiguous 0.3532 ambiguous -0.666 Destabilizing 0.001 N 0.171 neutral None None None None N
S/L 0.0878 likely_benign 0.0866 benign -0.384 Destabilizing 0.001 N 0.251 neutral None None None None N
S/M 0.1344 likely_benign 0.1343 benign -0.006 Destabilizing 0.497 N 0.43 neutral None None None None N
S/N 0.0983 likely_benign 0.0927 benign -0.673 Destabilizing 0.001 N 0.197 neutral N 0.485438956 None None N
S/P 0.8335 likely_pathogenic 0.8325 pathogenic -0.487 Destabilizing 0.364 N 0.455 neutral None None None None N
S/Q 0.3103 likely_benign 0.2871 benign -0.955 Destabilizing 0.22 N 0.355 neutral None None None None N
S/R 0.3217 likely_benign 0.2719 benign -0.52 Destabilizing 0.096 N 0.391 neutral N 0.478531626 None None N
S/T 0.0651 likely_benign 0.0651 benign -0.685 Destabilizing 0.001 N 0.138 neutral N 0.475435393 None None N
S/V 0.1318 likely_benign 0.1259 benign -0.487 Destabilizing 0.004 N 0.283 neutral None None None None N
S/W 0.2567 likely_benign 0.2497 benign -1.175 Destabilizing 0.958 D 0.471 neutral None None None None N
S/Y 0.1463 likely_benign 0.1375 benign -0.882 Destabilizing 0.331 N 0.493 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.